| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
786,383 |
|
|
Indirect Shares
|
362,461 |
|
|
| Direct
Value |
$788,702,830 |
|
|
|
Indirect Value
|
$363,530,260 |
|
|
| Total
Shares |
1,148,844 |
|
|
| Total
Value |
$1,152,233,090 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-16 |
786,383 |
2024-05-16 |
362,461 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2013-12-19 |
4 |
OE |
$21.25 |
$99,981 |
D/D |
4,705 |
1,068,343 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-08-27 |
4 |
D |
$351.33 |
$1,906,317 |
D/D |
(5,426) |
500,294 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
• • – |
2005-12-27 |
4 |
AS |
$14.80 |
$81,841 |
D/D |
(5,500) |
64,450 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-08-27 |
4 |
OE |
$314.31 |
$1,797,853 |
D/D |
5,720 |
505,720 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-01-03 |
4 |
D |
$19.69 |
$137,732 |
D/D |
(6,995) |
70,568 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Pres Regeneron Labs |
• • – |
2013-12-12 |
4 |
D |
$273.06 |
$2,561,849 |
D/D |
(9,382) |
1,106,612 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-09 |
4 |
OE |
$10.56 |
$100,940 |
D/D |
9,556 |
67,196 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-09 |
4 |
AS |
$23.80 |
$227,633 |
D/D |
(9,556) |
67,096 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Pres Regeneron Labs |
• • – |
2013-12-12 |
4 |
OE |
$260.44 |
$2,499,964 |
D/D |
9,599 |
1,115,994 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,277 |
64,817 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres Regen Res Labs |
• • – |
2012-12-17 |
4 |
OE |
$109.29 |
$1,133,228 |
D/D |
10,369 |
1,304,811 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2023-12-11 |
4 |
D |
$844.09 |
$10,838,960 |
D/D |
(12,841) |
752,486 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2023-02-06 |
4 |
AS |
$800.08 |
$10,552,255 |
I/I |
(13,189) |
200,504 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-01-02 |
4 |
AS |
$900.00 |
$15,163,200 |
I/I |
(16,848) |
180,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
• • – |
2005-12-27 |
4 |
D |
$15.67 |
$268,333 |
D/D |
(17,124) |
66,826 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-04-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
18,148 |
18,148 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-01-03 |
4 |
AS |
$20.00 |
$382,870 |
D/D |
(19,123) |
66,686 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-11-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
24,643 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
• • – |
2005-12-27 |
4 |
OE |
$12.75 |
$318,750 |
D/D |
25,000 |
83,950 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2023-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,155 |
765,327 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-09-18 |
4 |
S |
$20.69 |
$543,935 |
D/D |
(26,211) |
54,540 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2008-12-16 |
4 |
AS |
$16.40 |
$442,652 |
D/D |
(26,991) |
563,094 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-12-01 |
4 |
AS |
$58.86 |
$1,645,591 |
D/D |
(27,713) |
899,270 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO & Pres, REGN Res Labs |
• • – |
2012-01-05 |
4 |
AS |
$58.00 |
$1,607,354 |
D/D |
(27,713) |
833,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-01-03 |
4 |
OE |
$9.50 |
$285,000 |
D/D |
30,000 |
77,563 |
0 |
- |
|
145 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
